Acute appendicitis is one of the most frequent diagnosis in pediatric emergency services. Although the surgical approach has been the consensual gold-standard treatment [5, 6], nonoperative treatment has been safely applied in uncomplicated appendicitis cases, with no inferior outcomes in the resolution of acute appendicitis, avoiding surgical and anesthetic risks. However, as the appendix remains, this approach cannot prevent the risk of an appendicitis recurrence in the future, as it has been described increases over time. [7, 9, 10, 12–14, 16 18–24]
In 2012, our department introduced nonoperative treatment for acute appendicitis as an alternative option for uncomplicated cases. Over several years, NOTA has been implemented in patients with no clinical or radiological signs of complications, excluding cases with intraluminal appendicolith. In this study, about 55.3% of acute appendicitis cases were reported as uncomplicated; of those, 12.8% were included in the analysis. Accurate differentiation between complicated and uncomplicated acute appendicitis is essential to optimize the efficiency of nonoperative treatment [25]. The combination of clinical manifestation and radiological studies has made this distinction increasingly safe and precise, although sometimes, it may be uncertain before surgical intervention. Typically, uncomplicated appendicitis has a recent onset (< 48 hours), a relatively higher white blood cell count (< 18,000/µL), and the radiological absence of peritonitis, abscess, phlegmon, or fluid collection [11, 12, 26, 27]. Although the onset of symptoms was recorded in this study, it was not considered in patient selection, and there were no age limitations or specific blood inflammatory markers. Despite that, our sample's clinical characteristics resembled the definition of uncomplicated cases, with no statistical differences between cases of successful and failed NOTA.
Around 15% of all acute appendicitis cases were excluded from the analysis due to the presence of intraluminal appendicolith in ultrasonography. The association between appendicolith and nonoperative treatment failure and appendicitis recurrence has been described by several authors, and also, a prospective study by Machida et al.[27] reported an unacceptable failure rate of about 60% in children with uncomplicated appendicitis with appendicolith [7, 8, 22, 27–29]. Appendicolith is known to cause appendicitis by leading to the obstruction of the appendix lumen, which may be a physical impediment to resolving the infectious process. Nonoperative treatment is based on antibiotics to resolve the infection, but the blockage in the appendix lumen may hinder the therapy's success. Therefore, this study did not include patients with intraluminal appendicolith, even with uncomplicated acute appendicitis.
Our study reported a NOTA success rate of 89.5%, and twelve patients experienced NOTA failure. These findings align with literature reports, which indicate a nonoperative treatment success rate ranging from 87–97% and an average of 8–17% hospital failures, considering NOTA as a feasible option for uncomplicated appendicitis in children [7, 28, 30]. Additionally, a 2017 meta-analysis [25] reported antibiotic treatments in pediatric patients with uncomplicated appendicitis as feasible and effective without increasing the risk of complications, suggesting it should be considered for selected patients. This study reinforces the safety and feasibility of the NOTA approach in children with uncomplicated acute appendicitis as an alternative to surgery.
The concern of perforation, intra-abdominal abscess, or peritonitis due to surgery postponement or revocation has been discussed in the literature. Several studies have reported a 0-9.6% range of perforation rates with no further complications in pediatric nonoperative treatment [14, 19, 20, 31, 32]. In our study, a total of 3 patients (2.6% of all) of the unsuccessful group were diagnosed with perforated appendicitis, leading the authors to hypothesize that these cases may have been misapplied NOTA. Besides that, no intraoperative or postoperative complications were reported in these patients.
In the authors' opinion, considering NOTA as a resolutive treatment for acute appendicitis, the recurrence rate after this approach should be close to the appendicitis rate of the general population per year, which is about 5.7–50 patients per 100,000 inhabitants per year, also reported as a lifetime risk of around 9% [4]. Several articles have reported recurrence rates ranging from 16–28% at 1-year follow-up [10, 11, 13, 21, 27], with a meta-analysis accounting for a 16.1% recurrence rate, confirmed by histopathologic examination at 1-year follow-up. Another study by Patkova et al. [32] reported that most patients recurred in the first two months of follow-up, with most recurrences occurring within the first year of vigilance. In our study, there was a 10.3% recurrence rate over one year of follow-up, with most cases occurring at two months of follow-up. Considering this analysis, our study reported a recurrence rate similar to what has been described in the literature, still far from the original population appendicitis risk.
As improving NOTA outcomes is a priority for our department to minimize patient morbidity, avoid prolonging the best treatment option, and reduce the length of hospital stay, patient selection for NOTA must be improved for the highest success of this therapy. A 2023 prospective study reported a higher success rate in nonoperative treatment success in patients with short duration of symptoms, low leukocyte count, and smaller appendix size on ultrasound [31]. Also, Brecker G. et al., in 2024 [33], reported a high failure rate in patients older than 14 years old. In this study, the authors sought to identify predictive factors for the success of this therapy to enhance patient selection. After finding statistical differences in appendix diameter between the success and failure NOTA groups, a multivariable logistic regression analysis revealed an association between ultrasonographic appendiceal diameter and NOTA failure, with an 8.6 mm appendiceal diameter cut-off. According to these findings, appendix diameter negatively influences the success rate of nonoperative treatment in uncomplicated appendicitis. The wider the diameter, the greater the risk of failure, making surgery a preferable option in patients with uncomplicated appendicitis and an appendix diameter over 8.6mm. The authors hypothesize that by adding this exclusion criterion in NOTA patient selection, the failure rate could be reduced, improving clinical results for this treatment.
One of the advantages of the NOTA approach is the avoidance of surgery, and the role of interval appendectomy after a successful nonoperative treatment for uncomplicated appendicitis is unknown. Some authors have reported that nonoperative management without interval appendectomy is the most cost-effective strategy in children [20, 34]. A systematic review of complicated appendicitis presented the risk of recurrence as similar to the risk for morbidity associated with interval appendectomy. In our study, a total of 20% of patients chose to perform an interval appendectomy, primarily due to recurrent abdominal symptoms or parental request, with no evidence of appendicitis in histologic examination. Although acute appendicitis could rarely be an inaugural presentation of an underlying malignancy in about 0.5% of children [14, 35], this study suggests that appendectomy should only be a backup intervention in case of recurrence or as requested by the patient's family.
A significant limitation of this study is the non-randomized and retrospective nature, which may introduce sampling bias and the possibility of missing data in the medical records during follow-up. Additionally, there was no control group analysis, with uncomplicated appendicitis submitted to appendectomy, making approach comparisons impossible.
In our department's early stages of NOTA implementation, antibiotic therapy choices were not standardized, and different combinations were used. To reduce bias in the results, the authors excluded these cases from the analysis, reducing the sample size and consequently changing the strength of the results.
This work appears to be the first to assess the ultrasonographic appendix diameter as a negative predictor of NOTA success, establishing an 8.6mm cut-off value for appendix diameter in the application of NOTA in uncomplicated appendicitis cases. Nevertheless, the surgical approach in uncomplicated appendicitis has reported excellent outcomes, with meager rates of intra or postoperative complications. As such, NOTA application, in the author's opinion, should be restricted to inclusive criteria previously mentioned and, more importantly, to ultrasonographic appendix diameter cut-off, and with the family's consent, to achieve better outcomes with the minimum morbidity to patient and patient's family.
Given the findings of this study, it is now pertinent to initiate a prospective, preferably multicenter, study that utilizes appendiceal size assessed by ultrasonography as an inclusion or exclusion criterion. This approach could enhance our understanding of the predictive value of appendiceal size in the non-operative treatment of acute appendicitis. By adopting a standardized measure across multiple centers, we aim to refine patient selection and improve outcomes, ultimately reducing the morbidity associated with treatment failures.